Enhanced Label-Free Nanoplasmonic Cytokine Detection in SARS-CoV-2 Induced Inflammation Using Rationally Designed Peptide Aptamer
- 25 October 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 14 (43) , 48464-48475
Abstract
Rapid and precise serum cytokine quantification provides immense clinical significance in monitoring the immune status of patients in rapidly evolving infectious/inflammatory disorders, examplified by the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. However, real-time information on predictive cytokine biomarkers to guide targetable immune pathways in pathogenic inflammation is critically lacking, because of the insufficient detection range and detection limit in current label-free cytokine immunoassays. In this work, we report a highly sensitive localized surface plasmon resonance imaging (LSPRi) immunoassay for label-free Interleukin 6 (IL-6) detection utilizing rationally designed peptide aptamers as the capture interface. Benefiting from its characteristically smaller dimension and direct functionalization on the sensing surface via Au-S bonding, the peptide-aptamer-based LSPRi immunoassay achieved enhanced label-free serum IL-6 detection with a record-breaking limit of detection down to 4.6 pg/mL, and a wide dynamic range of ∼6 orders of magnitude (values from 4.6 to 1 × 106 pg/mL were observed). The immunoassay was validated in vitro for label-free analysis of SARS-CoV-2 induced inflammation, and further applied in rapid quantification of serum IL-6 profiles in COVID-19 patients. Our peptide aptamer LSPRi immunoassay demonstrates great potency in label-free cytokine detection with unprecedented sensing capability to provide accurate and timely interpretation of the inflammatory status and disease progression, and determination of prognosis.Keywords
Funding Information
- National Cancer Institute (R01CA243001)
- Office of Integrative Activities (OIA-2033454)
- Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET-1943302, CBET-2030828)
- National Institute of General Medical Sciences (R35GM133795)
This publication has 65 references indexed in Scilit:
- Localized Surface Plasmon Resonance SensorsChemical Reviews, 2011
- SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-κB pathway in human monocyte macrophages in vitroVirus Research, 2009
- Rational Selection of Gold Nanorod Geometry for Label-Free Plasmonic BiosensorsACS Nano, 2009
- Label-free technologies for quantitative multiparameter biological analysisAnalytical and Bioanalytical Chemistry, 2009
- Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman diseaseBlood, 2008
- Ab Initio Folding of Proteins with All-Atom Discrete Molecular DynamicsStructure, 2008
- Biosensing with plasmonic nanosensorsNature Materials, 2008
- Up-regulation of IL-6 and TNF-α induced by SARS-coronavirus spike protein in murine macrophages via NF-κB pathwayVirus Research, 2007
- Localized Surface Plasmon Resonance Spectroscopy and SensingAnnual Review of Physical Chemistry, 2007
- Nanoscale Optical Biosensor: Short Range Distance Dependence of the Localized Surface Plasmon Resonance of Noble Metal NanoparticlesThe Journal of Physical Chemistry B, 2004